High Selectivity and Reduced Byproducts
Pathway streamlining ensures that carbon flux is directed solely to 1,2-PD, leading to a higher purity crude broth .
1,2-Propanediol (1,2-PD) is a versatile chemical used in cosmetics, pharmaceuticals, food additives, and for synthesizing unsaturated polyester resins. Traditional production via petrochemical synthesis relies on non-renewable propylene , and the process often involves high pressure and temperature. While microbial synthesis from glycerol (a crude biodiesel byproduct) offers a sustainable route, a major challenge is poor selectivity , resulting in the co-production of large amounts of unwanted byproducts like ethanol, acetate, and 2,3-butanediol.
CD Biosynsis offers a synthetic biology service focused on establishing a clean, high-yield bioproduction route. Our core strategy involves modification of the glycerol metabolism pathway in Klebsiella (or similar hosts) to enhance carbon flux into the 1,2-PD branch while shutting down competing pathways. This is coupled with the directed evolution of dehydrogenase (e.g., diol dehydratase and propanediol dehydrogenase) to boost catalytic efficiency and improve specificity , ensuring the final product is 1,2-PD with minimal coproducts. This integrated approach aims to deliver a high-titer, high-purity, and cost-effective 1,2-PD product from sustainable glycerol feedstock.
Get a QuoteDeveloping a cost-effective and high-selectivity bioproduction route for 1,2-PD faces these critical limitations:
A cost-effective solution must streamline the metabolic pathway to ensure high product selectivity.
CD Biosynsis utilizes advanced synthetic biology to optimize 1,2-PD production in Klebsiella or engineered E. coli :
Modification of Glycerol Metabolism Pathway in Klebsiella
We employ genome editing to knock out competing byproduct pathways (e.g., ethanol, butanediol) and upregulate the key enzymes (DhaB, PD dehydrogenase) to force flux toward 1,2-PD.
Directed Evolution of Dehydrogenase
We perform directed evolution on propanediol dehydrogenase (Pdh) to enhance its catalytic efficiency and specificity for 1,2-PD formation, mitigating side reactions.
Cofactor Engineering for NADH Balance
We modify auxiliary pathways to ensure a stable and sufficient supply of NADH , which is essential for the final reduction step in 1,2-PD synthesis.
Enzyme Stabilization and Cofactor-Free Alternatives
We focus on engineering the host for improved B12metabolism or introducing alternative, B}12$-independent enzyme systems to simplify medium complexity and reduce costs.
This systematic approach is focused on achieving high carbon yield and minimizing the expensive separation of coproducts.
Our 1,2-PD engineering service is dedicated to pursuing the following production goals:
High Selectivity and Reduced Byproducts
Pathway streamlining ensures that carbon flux is directed solely to 1,2-PD, leading to a higher purity crude broth .
Sustainable Glycerol Utilization
Uses crude glycerol, a waste stream from biodiesel production, as the sole carbon source, enhancing the sustainability of both industries.
Simplified Downstream Processing
Minimized coproduct formation reduces the number of purification steps required, lowering total manufacturing costs. [Image of Cost Reduction Icon]
High NADH Efficiency
Cofactor engineering ensures the redox balance required for the pathway is maintained optimally, maximizing specific productivity.
High Titer and Productivity
Engineered strains are designed to achieve high product concentrations in the fermenter, improving volumetric productivity.
We provide a biosynthetic platform aimed at maximizing the yield and minimizing the purification cost of sustainable 1,2-PD production.
Our 1,2-PD strain engineering service follows a standardized, iterative research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and product purity.
Explore the potential for a high-selectivity, sustainable 1,2-PD supply. CD Biosynsis provides customized strain and enzyme engineering solutions:
Why is crude glycerol preferred as a feedstock?
Crude glycerol is a major low-cost byproduct of biodiesel production . Its utilization converts a waste stream into a valuable chemical, significantly improving the overall economic and environmental viability of the process.
What is the significance of "poor selectivity"?
Poor selectivity means the engineered microbe is still producing large amounts of chemicals other than 1,2-PD. This forces the manufacturer to spend more money and energy separating 1,2-PD from these impurities, undermining the cost benefit of biosynthesis.
What is the role of diol dehydratase (DhaB)?
DhaB is the key enzyme in the 1,2-PD pathway , catalyzing the conversion of glycerol to 3-HPA (3-hydroxypropionaldehyde), which is then reduced to 1,2-PD. It requires the B12cofactor and is a major bottleneck due to its oxygen sensitivity.
How does cofactor engineering enhance the process?
The 1,2-PD pathway consumes NADH. Cofactor engineering involves adding or enhancing metabolic pathways (like the pentose phosphate pathway) that generate NADH at the same rate it is consumed , sustaining high product synthesis without cell starvation.
What is the estimated project timeline?
A project involving complex metabolic pathway modification and enzyme directed evolution in a non-model host typically requires 24-28 weeks for final strain delivery and comprehensive performance validation.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.